Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Bragadiru – page 20

671 clinical trials in Bragadiru, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bragadiru at a glance
671
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

671 trials in Bragadiru

Open in trial search

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.

Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate
  • Sponsor:Blueprint Medicines Corp.

Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Study on the Effectiveness and Safety of Metronidazole, Neomycin Sulfate, and Nystatin for Women with Bacterial Vaginosis and Yeast Infections

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Metronidazole
  • Sponsor:Antibiotice S.A.

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Psychotic disorder+1

Recruiting

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Merck Sharp & Dohme LLC

Hyperkalaemia

Recruiting

Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Sodium Zirconium Cyclosilicate
  • Sponsor:AstraZeneca AB

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Astellas Pharma Global Development Inc.

Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Diakonhjemmet Sykehus AS

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bragadiru

What the registry says about research in the country

01 Respiratory Disease Management

Innovative research focusing on moderate to severe asthma treatments, evaluating new inhaler formulations and their safety profiles. Studies aim to improve bronchodilation and reduce exacerbations in patients following GINA guidelines.

  • Asthma Control Studies
  • Inhaler Technology Assessment
  • Bronchodilation Research

Multiple trials examining maintenance therapy optimization for better patient outcomes.

02 COPD Research Initiatives

Comprehensive studies exploring chronic obstructive pulmonary disease treatments, including evaluation of triple combination therapies and novel biological agents for moderate to severe cases.

  • Lung Function Enhancement
  • Exacerbation Prevention
  • Long-term Safety Studies

Focus on improving quality of life for patients with chronic respiratory conditions.

03 Advanced Therapeutic Solutions

Investigation of targeted treatments for severe eosinophilic asthma and development of innovative rescue medications. Research includes long-term efficacy studies of biological treatments.

  • Biological Therapy Evaluation
  • Rescue Medication Development
  • Extended Duration Trials

Emphasis on personalized treatment approaches for specific patient populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.